Avantax Advisory Services Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,290 shares of the healthcare conglomerate’s stock after selling 74 shares during the quarter. Avantax Advisory Services Inc.’s holdings in UnitedHealth Group were worth $16,280,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Robbins Farley acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $25,000. NewSquare Capital LLC increased its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the period. Strategic Investment Solutions Inc. IL acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $35,000. Annapolis Financial Services LLC increased its stake in shares of UnitedHealth Group by 38.6% during the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after acquiring an additional 22 shares during the period. Finally, WFA of San Diego LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at approximately $39,000. Institutional investors and hedge funds own 85.69% of the company’s stock.
UnitedHealth Group Price Performance
Shares of UNH stock opened at $510.28 on Friday. The stock has a 50 day moving average of $528.32 and a two-hundred day moving average of $517.39. The company has a current ratio of 0.79, a quick ratio of 0.80 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The company has a market capitalization of $471.97 billion, a P/E ratio of 21.40, a P/E/G ratio of 1.38 and a beta of 0.54.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, December 4th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, December 1st. This represents a $7.52 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is 31.54%.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Oppenheimer restated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a research note on Monday, October 23rd. HSBC reaffirmed a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. StockNews.com cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. Finally, Stephens decreased their price target on UnitedHealth Group from $615.00 to $605.00 and set an “overweight” rating for the company in a research note on Tuesday, January 16th. One analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $575.79.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the transaction, the director now owns 635,528 shares of the company’s stock, valued at $349,788,255.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.35% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- Most Volatile Stocks, What Investors Need to Know
- MarketBeat Week in Review – 1/29 – 2/2
- Bank Stocks – Best Bank Stocks to Invest In
- How to start investing in penny stocks
- How to Invest in Small Cap Stocks
- Exploring communication services stocks: A comprehensive guide
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.